Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mydriasert vs Eyedrops for Mydriasis in Neonates
NCT00642135Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2006
- Primary completion
- Feb 2008
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of Mydriasert in retinopathy of prematurity (ROP), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2006; status: terminated.
02
Drugs
Mydriasert
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT00642135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642135.